Ravi S Nunna1, Syed Khalid2, Ryan G Chiu3, Rown Parola3, Richard G Fessler4, Owoicho Adogwa5, Ankit I Mehta3. 1. Department of Neurosurgery, Swedish Medical Center, Seattle, WA, USA ravisnunna@gmail.com. 2. Department of Surgery, Rush University Medical Center, Chicago, IL, USA. 3. Department of Neurosurgery, University of Illinois-Chicago Medical Center, Chicago, IL, USA. 4. Department of Neurosurgery, Rush University Medical Center, Chicago, IL, USA. 5. Department of Neurosurgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Abstract
BACKGROUND: There is unclear evidence regarding the optimal surgical approach for multilevel cervical spondylotic myelopathy (CSM). The objective of this study was to compare complications, outcomes, and narcotic use in anterior discectomy and fusion (ACDF) vs posterior decompression and fusion (PCDF) in CSM patients. STUDY DESIGN: Registry-based retrospective cohort analysis. METHODS: Patients undergoing 3-level ACDF or PCDF for CSM between 2007 and 2017 were identified from the Humana Claims Database using relevant procedure codes. Propensity score-matched groups were compared in regards to complications, outcomes, and narcotic use. RESULTS: Propensity score matching generated equal cohorts of 6124 patients. The posterior fusion group had a higher rate of urinary tract infection (OR 2.47, P < 0.0001), deep vein thrombosis (OR 1.90, P < 0.0001), and pulmonary embolism (OR 1.75, P < 0.0001). In regards to 30-day outcomes, the posterior approach demonstrated higher rates of stroke (OR 1.68, P < 0.0001), wound dehiscence (OR 5.59, P < 0.0001), Surgical site infection (SSI) (OR 4.76, P < 0.0001), wound revision surgery (OR 3.02, P < 0.0001), and all-cause readmission (OR 2.01, P < 0.0001). One-year outcomes revealed higher rates of pseudarthrosis (4.7% vs 2.0%, OR 2.43, P < 0.0001) and revision or extension surgery (OR 2.33, P < 0.0001) in the posterior fusion cohort. These patients also demonstrated significantly higher mean morphine milligram equivalent used at 30 days (OR 1.19, P < 0.0001), as well as 60 (OR 1.20, P < 0.0001), 90 (OR 1.21, P < 0.0001), and 120 (OR 1.21, P < 0.0001) days. CONCLUSIONS: This nationwide propensity-matched analysis of multilevel CSM patients found the posterior approach to be associated with increased rates of inpatient complications, wound complications, 30-day readmission, 1-year pseudarthrosis, and 1-year revision or extension surgery. These patients also demonstrated higher levels of narcotic use up to 120 days after surgery. CLINICAL RELEVANCE: The posterior approach for treatment of CSM may be associated with increased rates of short- and long-term complications in addition to increased narcotic consumption in comparison to the anterior approach. This manuscript is generously published free of charge by ISASS, the International Society for the Advancement of Spine Surgery.
BACKGROUND: There is unclear evidence regarding the optimal surgical approach for multilevel cervical spondylotic myelopathy (CSM). The objective of this study was to compare complications, outcomes, and narcotic use in anterior discectomy and fusion (ACDF) vs posterior decompression and fusion (PCDF) in CSM patients. STUDY DESIGN: Registry-based retrospective cohort analysis. METHODS: Patients undergoing 3-level ACDF or PCDF for CSM between 2007 and 2017 were identified from the Humana Claims Database using relevant procedure codes. Propensity score-matched groups were compared in regards to complications, outcomes, and narcotic use. RESULTS: Propensity score matching generated equal cohorts of 6124 patients. The posterior fusion group had a higher rate of urinary tract infection (OR 2.47, P < 0.0001), deep vein thrombosis (OR 1.90, P < 0.0001), and pulmonary embolism (OR 1.75, P < 0.0001). In regards to 30-day outcomes, the posterior approach demonstrated higher rates of stroke (OR 1.68, P < 0.0001), wound dehiscence (OR 5.59, P < 0.0001), Surgical site infection (SSI) (OR 4.76, P < 0.0001), wound revision surgery (OR 3.02, P < 0.0001), and all-cause readmission (OR 2.01, P < 0.0001). One-year outcomes revealed higher rates of pseudarthrosis (4.7% vs 2.0%, OR 2.43, P < 0.0001) and revision or extension surgery (OR 2.33, P < 0.0001) in the posterior fusion cohort. These patients also demonstrated significantly higher mean morphine milligram equivalent used at 30 days (OR 1.19, P < 0.0001), as well as 60 (OR 1.20, P < 0.0001), 90 (OR 1.21, P < 0.0001), and 120 (OR 1.21, P < 0.0001) days. CONCLUSIONS: This nationwide propensity-matched analysis of multilevel CSM patients found the posterior approach to be associated with increased rates of inpatient complications, wound complications, 30-day readmission, 1-year pseudarthrosis, and 1-year revision or extension surgery. These patients also demonstrated higher levels of narcotic use up to 120 days after surgery. CLINICAL RELEVANCE: The posterior approach for treatment of CSM may be associated with increased rates of short- and long-term complications in addition to increased narcotic consumption in comparison to the anterior approach. This manuscript is generously published free of charge by ISASS, the International Society for the Advancement of Spine Surgery.
Authors: Caterina Y Liu; Corinna C Zygourakis; Seungwon Yoon; Tamara Kliot; Christopher Moriates; John Ratliff; R Adams Dudley; Ralph Gonzales; Praveen V Mummaneni; Christopher P Ames Journal: Spine (Phila Pa 1976) Date: 2017-08-01 Impact factor: 3.468
Authors: Michael G Fehlings; Sean Barry; Branko Kopjar; Sangwook Tim Yoon; Paul Arnold; Eric M Massicotte; Alexander Vaccaro; Darrel S Brodke; Christopher Shaffrey; Justin S Smith; Eric Woodard; Robert J Banco; Jens Chapman; Michael Janssen; Christopher Bono; Rick Sasso; Mark Dekutoski; Ziya L Gokaslan Journal: Spine (Phila Pa 1976) Date: 2013-12-15 Impact factor: 3.468
Authors: Brian K Kwon; Charles G Fisher; Michael C Boyd; John Cobb; Hilary Jebson; Vanessa Noonan; Peter Wing; Marcel F Dvorak Journal: J Neurosurg Spine Date: 2007-07
Authors: Ziad A Audat; Mohammad D Fawareh; Ahmad M Radydeh; Moutasem M Obeidat; Mohannad A Odat; Khaldoon M Bashaireh; Mohammad M Barbarawi; Murad T Nusairat; Amna B Ibraheem; Mohammad Z Audat Journal: SAGE Open Med Date: 2018-04-10
Authors: Jetan H Badhiwala; Christopher D Witiw; Farshad Nassiri; Muhammad A Akbar; Alireza Mansouri; Jefferson R Wilson; Michael G Fehlings Journal: Neurosurgery Date: 2019-04-01 Impact factor: 4.654